SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Prilenia and Ferrer to Present Pridopidine Data and PREVAiLS Updates at NEALS Meeting

The companies plan to share a post hoc analysis of a subgroup of ALS participants from the Phase 2 HEALEY Platform study at the NEALS Consortium 2026 Annual Meeting.

Related stories